These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 27856798)
1. The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity. Wieczorek M; Tcherkezian J; Bernier C; Prota AE; Chaaban S; Rolland Y; Godbout C; Hancock MA; Arezzo JC; Ocal O; Rocha C; Olieric N; Hall A; Ding H; Bramoullé A; Annis MG; Zogopoulos G; Harran PG; Wilkie TM; Brekken RA; Siegel PM; Steinmetz MO; Shore GC; Brouhard GJ; Roulston A Sci Transl Med; 2016 Nov; 8(365):365ra159. PubMed ID: 27856798 [TBL] [Abstract][Full Text] [Related]
2. Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin. Cruz-Monserrate Z; Vervoort HC; Bai R; Newman DJ; Howell SB; Los G; Mullaney JT; Williams MD; Pettit GR; Fenical W; Hamel E Mol Pharmacol; 2003 Jun; 63(6):1273-80. PubMed ID: 12761336 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents. Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019 [TBL] [Abstract][Full Text] [Related]
4. [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine]. Tsvetkov FO; Kulikova AA; Devred F; Zerniĭ EIu; Lafitte D; Makarov AA Mol Biol (Mosk); 2011; 45(4):697-702. PubMed ID: 21954603 [TBL] [Abstract][Full Text] [Related]
5. HURP binding to the vinca domain of β-tubulin accounts for cancer drug resistance. Saju A; Chen PP; Weng TH; Tsai SY; Tanaka A; Tseng YT; Chang CC; Wang CH; Shimamoto Y; Hsia KC Nat Commun; 2024 Oct; 15(1):8844. PubMed ID: 39397030 [TBL] [Abstract][Full Text] [Related]
6. In situ response to vinka alkaloids by microtubules in cultured post-implanted mouse embryos. Meininger V; Binet S; Chaineau E; Fellous A Biol Cell; 1990; 68(1):21-9. PubMed ID: 2180513 [TBL] [Abstract][Full Text] [Related]
7. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line. Lobert S; Fahy J; Hill BT; Duflos A; Etievant C; Correia JJ Biochemistry; 2000 Oct; 39(39):12053-62. PubMed ID: 11009620 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Jordan MA Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):1-17. PubMed ID: 12678749 [TBL] [Abstract][Full Text] [Related]
9. Vinflunine: a new vision that may translate into antiangiogenic and antimetastatic activity. Aparicio LM; Pulido EG; Gallego GA Anticancer Drugs; 2012 Jan; 23(1):1-11. PubMed ID: 22027536 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine. Ngan VK; Bellman K; Hill BT; Wilson L; Jordan MA Mol Pharmacol; 2001 Jul; 60(1):225-32. PubMed ID: 11408618 [TBL] [Abstract][Full Text] [Related]
12. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules. Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627 [TBL] [Abstract][Full Text] [Related]
13. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells. Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901 [TBL] [Abstract][Full Text] [Related]
14. [Microtubules and antineoplastic drugs]. Arioka H; Saijo N Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of hybrid molecules targeting the vinca domain of tubulin. Gherbovet O; Sánchez-Murcia PA; García Alvarez MC; Bignon J; Thoret S; Gago F; Roussi F Org Biomol Chem; 2015 Mar; 13(10):3144-54. PubMed ID: 25634805 [TBL] [Abstract][Full Text] [Related]
16. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules. Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Owellen RJ; Hartke CA; Dickerson RM; Hains FO Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766 [TBL] [Abstract][Full Text] [Related]
18. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Himes RH Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids. Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542 [TBL] [Abstract][Full Text] [Related]